benzquinamide has been researched along with Emesis in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Benzquinamide-HCl (Promecon), a new antiemetic agent, was applied as an intravenous infusion in different doses for prevention of cancer chemotherapy-induced vomiting to 108 patients." | 7.66 | [Dose-response relationship of intravenous administration of benzquinamide hydrochloride for suppression of cytostatic-induced emesis]. ( Nietsch, P, 1983) |
| "Sixty-four patients receiving cancer chemotherapy known to induce severe emesis entered a randomized double-blind study of the antiemetic efficacy of haloperidol (Haldol) and benzquinamide (Emetecon)." | 5.05 | Specific antiemetics for specific cancer chemotherapeutic agents: haloperidol versus benzquinamide. ( Gagen, M; Neidhart, JA; Wilson, HE; Young, D, 1981) |
| "Benzquinamide-HCl (Promecon), a new antiemetic agent, was applied as an intravenous infusion in different doses for prevention of cancer chemotherapy-induced vomiting to 108 patients." | 3.66 | [Dose-response relationship of intravenous administration of benzquinamide hydrochloride for suppression of cytostatic-induced emesis]. ( Nietsch, P, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nietsch, P | 1 |
| Neidhart, JA | 1 |
| Gagen, M | 1 |
| Young, D | 1 |
| Wilson, HE | 1 |
1 trial available for benzquinamide and Emesis
| Article | Year |
|---|---|
Specific antiemetics for specific cancer chemotherapeutic agents: haloperidol versus benzquinamide.
Topics: Adult; Antineoplastic Agents; Cisplatin; Clinical Trials as Topic; Double-Blind Method; Doxorubicin; | 1981 |
1 other study available for benzquinamide and Emesis
| Article | Year |
|---|---|
[Dose-response relationship of intravenous administration of benzquinamide hydrochloride for suppression of cytostatic-induced emesis].
Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Female | 1983 |